Fed Regist. 2018 Feb 27;83(39):8355-7.
Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems. Final order.
Abstract
The Food and Drug Administration (FDA or we) is classifying Lynch syndrome test systems into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the Lynch syndrome test systems' classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
- PMID:
- 29932614
- [Indexed for MEDLINE]
No hay comentarios:
Publicar un comentario